α2-macroglobulin and α1-inhibitor-3 mRNA expression in the rat liver after slow interleukin-1 stimulation

• Main Authors: T. Gudmundsson, P. Björk, K. Ohlsson
• Format: Article
• Language: English
• Published: Hindawi Limited 1996-01-01
• Series: Mediators of Inflammation
• Online Access: http://dx.doi.org/10.1155/S0962935196000385

In this study we have investigated total fiver RNA and the expression of mRNA in the rat fiver in vivo after a slow stimulation of interleukin-1. A total dose of 4 μg interleukin-1β was administered via a subcutaneously implanted osmotic minipump over a period of 7 days. Plasma concentrations of α2-macroglobulin manifested a rapid increase, reaching a peak on day 2, while α1-inhibitor-3 manifested a marked initial decrease to 50% of the baseline level, followed by a tendency to increase again. For measurement of total RNA and specific mRNAs from the fiver, rats were sacrificed at different times during the experimental period. Total RNA peaked at 6 h, the level being approximately 60% higher than baseline value. Specific mRNA from the liver for α2-macroglobulin and α1-inhibitor-3 were quantified using laser densitometry on slot blots. The amounts measured during the experimental period agreed with the pattern of corresponding plasma protein levels. From barely detectable amounts at baseline, α2-macroglobulin mRNA peaked on day 1, and then declined. Levels of α1-inhibitor-3 mRNA manifested an initial increase at 3 h, but then declined and remained low until day 5 when there was a tendency towards an increase. It was concluded that the levels of plasma concentrations of α2-macroglobulin and α1-inhibitor-3 are mainly regulated at the protein synthesis level, and that long-term interleukin-1β release could not override the initial acute phase protein counteracting mechanism triggered.